Quality of Life of Patients With a History of Drug Allergy in Thailand

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Chulalongkorn University
Sponsor:
Collaborator:
Mahidol University
Information provided by (Responsible Party):
Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01666470
First received: August 12, 2012
Last updated: July 21, 2014
Last verified: July 2014
  Purpose

Quality of life of patients with a history of drug allergy in Thailand will be studied.


Condition Intervention
Quality of Life
Other: Questionnaires

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Quality of Life of Patients With a History of Drug Allergy in Thailand

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • The quality of life of Thai patients with a history of drug allergy evaluating by DrHy-Q (Thai version) [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The correlation between DrHy-Q (Thai version) and WHOQOL-BREF-THAI [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Pearson correlation coefficient between scores from DrHy-Q (Thai version) and WHOQOL-BREF-THAI in patients with a history of drug allergy will be analyzed.


Estimated Enrollment: 400
Study Start Date: August 2012
Estimated Study Completion Date: September 2014
Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Drug allergy patients
Patients with a history of drug allergy in Thailand
Other: Questionnaires
DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked

Detailed Description:

Thai patients with a history of drug allergy will be evaluated for their quality of life based on drug hypersensitivity quality of life questionnaire (DrHy-Q; Thai version) and The World Health Organization Quality of Life instrument (WHOQOL-BREF-THAI)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Thai patients with a history of drug allergy

Criteria

Inclusion Criteria:

  • Have a history of drug allergy
  • At least 18 years of age

Exclusion Criteria:

  • Not be able to understand Thai language
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01666470

Contacts
Contact: Jettanong Klaewsongkram, MD 662-2564152 Jettanong.K@chula.ac.th

Locations
Thailand
Faculty of Medicine, Chulalongkorn University Recruiting
Bangkok, Thailand, 10330
Contact: Jettanong Klaewsongkram, MD    662-2564152    Jettanong.K@chula.ac.th   
Principal Investigator: Jettanong Klaewsongkram, MD         
Faculty of Medicine, Siriraj Hospital, Mahidol University Recruiting
Bangkok, Thailand
Contact: Torpong Thongngarm, MD    662-4198263      
Principal Investigator: Torpong Thongngarm, MD         
Faculty of Medicine, Ramathibodi Hospital, Mahidol University Recruiting
Bangkok, Thailand
Contact: Ticha Rerkpattanapipat, MD    662-2011477      
Principal Investigator: Ticha Rerkpattanapipat, MD         
Phramongkutklao College of Medicine Recruiting
Bangkok, Thailand
Contact: Atik Sangasapaviliya, MD    662-3549085      
Principal Investigator: Atik Sangasapaviliya, MD         
Sponsors and Collaborators
Chulalongkorn University
Mahidol University
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
  More Information

Additional Information:
No publications provided

Responsible Party: Jettanong Klaewsongkram, Head of Division of Allergy and Clinical Immunology, Department of Medicine, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01666470     History of Changes
Other Study ID Numbers: Chula-ARC 001/12
Study First Received: August 12, 2012
Last Updated: July 21, 2014
Health Authority: Thailand: Ethical Committee

Keywords provided by Chulalongkorn University:
Quality of life

Additional relevant MeSH terms:
Drug Hypersensitivity
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 24, 2014